Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1256801 10.3389/fphar.2023.1256801 Pharmacology Correction Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report Yan et al. 10.3389/fphar.2023.1256801 Yan Ningning * † Huang Siyuan † Li Linlin Guo Qianqian Geng Di Zhang Huixian Guo Sanxing * Li Xingya * Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Ningning Yan, yanningrj@alumni.sjtu.edu.cn; Xingya Li, fcclixy1@zzu.edu.cn; Sanxing Guo, sanxing134@hotmail.com

These authors have contributed equally to this work and share first authorship

 26 07 2023 2023 14 1256801 20 07 2023 21 07 2023 Copyright © 2023 Yan, Huang, Li, Guo, Geng, Zhang, Guo and Li. 2023 Yan, Huang, Li, Guo, Geng, Zhang, Guo and Li

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report by Yan N, Huang S, Li L, Guo Q, Geng D, Zhang H, Guo S and Li X (2022). Front. Pharmacol. 13:898623. doi: 10.3389/fphar.2022.898623 immune checkpoint inhibitor NSCLC ROS1 chemo-immunotherapy lung adenocarcinoma section-at-acceptance Pharmacology of Anti-Cancer Drugs

In the published article, the names in the Author list were incorrectly written as “Ning Yan*†, Si Huang†, Lin Li, Qian Guo, Di Geng, Hui Zhang, San Guo* and Xing Li*.” The correct spelling is “Ningning Yan*†, Siyuan Huang†, Linlin Li, Qianqian Guo, Di Geng, Huixian Zhang, Sanxing Guo* and Xingya Li*.” The updated Author Contributions statement appears below.

“All authors participated in the diagnosis and treatment process. NY, SH, and XL diagnosed the patient and developed the treatment plan. NY, SH, LL, QG, DG, and HZ participated in the follow-up course. NY, SH, SG, and XL wrote the original manuscript. All authors contributed to the article and approved the submitted version.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.